Pivotal Financial Consulting

2021 - Clinical Research Bounces Back

Biotech - Don't Call It a Comeback

COVID-19 - Clinical Trial Impact

COVID-19 - Assessing the Data

CRO Account Directors Make A Big Impact

Turnover - Is it Always Bad?

Mid-Size CRO Competitive Landscape

Recent Biotech IPO Analysis

Biotech FDA Approvals Peak

CRO Utilization - Part #2

CRO Utilization Part #1

Biotech's Impact on Drug Development

Effective Communication – The Overlooked CRO Advantage

Where CRO Size Doesn't Matter - Glassdoor.com

Project Leaders: The Unsung CRO Heroes

CRO: Does Size Matter?

Contractors vs. Employees: When CROs Outsource

Quick Impact - PRA Acquires Symphony Health

Parexel Backlog Adjustments & Burn Rates

Simple Metrics Clinical Research Organizations Should Utilize - But Don't

Pediatric Clinical Trials - The Niche That Shouldn't Be a Niche

Top Missteps Made By Owners When Selling Their Business

Hooray - It's Budget Season - Not!

Patient Recruitment: Clinical Research's "White Whale"?

CRO Consolidations - Does 1 + 1 = 3?

Improving CRO Gross Margins with Project Margins

What Can a CRO do to Deal with the Cancellation Bugaboo?

Buying or Selling a CRO? Better Check the Backlog

The Impact of R&D and Medical Device Trends on Small to Mid-Size CROs

Why CRO Win Rates Matter

Will More Large CROs be Acquired?

Have Small and Mid-Size CRO’s Overachieved?